Twist Bioscience Corporation (0ME)
FSX
145.25
+12.45 (+9.37%)
Closed
Oct 9, 2026
Day's Range
135.80145.25
52 wk Range
21.69183.50
Financial Statements - 0ME - Twist Bioscience Corporation
Revenue
376.57M▲ 39.9%
Net Income
-77.67M▲ 56.7%Net Margin -20.6%
EBITDA
-160.25M▼ 41.4%
Free Cash Flow
-75.63M▼ 27.1%
Income Statement
| Period Ending | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 | 2020-09-30 |
|---|---|---|---|---|---|---|
| Sales | 376.57M | 269.22M | 245.10M | 203.56M | 132.33M | 90.10M |
| Cost of Goods | 185.57M | 154.51M | 155.38M | 119.33M | 80.62M | 61.40M |
| Gross Profit | 191M | 114.70M | 89.72M | 84.23M | 51.71M | 28.69M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -136.25M | -151.31M | -206.90M | -249.02M | -153.26M | -117.57M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | 47.94M | -40.92M | -10.92M | 17.76M | -836K | -22.68M |
| Pre Tax Income | -76.95M | -179.06M | -203.46M | -228.27M | -154.02M | -139.54M |
| Income Tax | 719K | 481.71K | 1.15M | -10.41M | -1.93M | 382K |
| Net Income | -77.67M | -179.54M | -204.61M | -217.86M | -152.09M | -139.93M |
| EPS Basic | -1.3 | -3.6 | -3.6 | -4.04 | -3.15 | -3.57 |
| EPS Diluted | -1.3 | -3.6 | -3.6 | -4.04 | -3.15 | -3.57 |
| Basic Shares Outstanding | 59.80M | 49.90M | 58.40M | 55.32M | 49.54M | 40.23M |
| Diluted Shares Outstanding | 59.80M | 49.90M | 58.40M | 55.32M | 49.54M | 40.23M |
| Ebit | -136.25M | -179.03M | -203.46M | -228.19M | -153.66M | -138.76M |
| Ebitda | -160.25M | -113.35M | -163.89M | -230.53M | -144.44M | -109.58M |
| Net Income Continuous Operations | -77.67M | -179.54M | -204.61M | -217.86M | -152.09M | -139.93M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
